Mirum Pharmaceuticals, Inc.

Associate Director, Strategic Engagement (Thought Leader Liaison), Northeast

Mirum Pharmaceuticals, Inc.  •  United States (Remote)  •  2 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Associate Director, Strategic Engagement also known as Thought Leader Liaison (TLL) serves as a key strategic partner between Mirum Pharmaceuticals and the healthcare community, focusing on cultivating and maintaining relationships with key opinion leaders (KOLs), thought leaders, and other external stakeholders. This role is responsible for building scientific credibility, supporting brand strategy, and ensuring aligned, compliant engagement with external experts to enhance awareness and education. Area of focus will largely be supporting the Hepatology and Gastroenterology community supporting our existing and future products in Alagille, PFIC, PBC, PSC and Hepatitis D.

States likely to be included in territory include: NY, NJ, CT, MA, RI, VT, NH, ME

JOB FUNCTIONS/RESPONSIBILITIES

  • Develop and communicate the strategic vision and operational plan for engaging KOLs.
  • Develop and oversee development and execution of individual KOL Mapping KOLs plans.
  • Partner closely with the Director, Marketing – KOL Strategy and Congress Planning to ensure alignment.
  • Build and maintain productive, collaborative, and compliant relationships with peers leading teams in Marketing, Market Access, Patient Services, and Medical Affairs.
  • Work closely with the Field Sales team on the execution of all thought leader-related initiatives and programs.
  • Build mechanisms to collect insights, synthesize and integrate them, and communicate to brand to inform tactics
  • Bring thought leaders closer to Mirum by ensuring compliant, value-added connections across the organization.
  • Collaborate with Medical Leadership on engagement strategy and planning as appropriate, including support and coordination of commercial advisory boards.
  • Engage with KOLs to solicit feedback that shapes and informs brand strategy.
  • Contribute Marketing strategy for conferences/congresses including sponsorships, communication/messaging, and advocacy group engagement.
  • Work in partnership with the Marketing portfolio leaders and field leadership to develop appropriate KPIs and metrics to support the brand marketing and executional goals.
  • Act as primary point of contact for the field, maintaining an effective two-way dialogue on KOL engagement, potential speaker identification, and up-and-coming thought leaders and experts.
  • Analyze market data, confirm data reliability and inform team stakeholders to make informed decisions.
  • Proactively engage partners in Legal and Compliance to ensure programs and processes are being delivered with the highest ethical standards

QUALIFICATIONS

Education/Experience:

  • Bachelor’s degree (required)
  • A minimum of 10 years of pharmaceutical or related industry experience required, mostly in a customer-facing capacity
  • A minimum of 3 years of working with Hepatology KOLs preferred
  • A minimum of 2 years of working as a Thought Leader Liaison preferred

Knowledge, Skills and Abilities:

  • Strategic thinking and an ability to work in a hands-on manner to deliver on multiple priorities
  • Able to draw insights from a variety of sources, understands market and competition.
  • Compiles relevant data from appropriate sources and performs analysis.
  • Experience working successfully within a cross collaborative internal environment.
  • Synthesize complex and diverse information, recognizes trends and/or interrelationship.
  • Ability to meet objectives and deadlines, promote efficiency and effectiveness, and incorporate improvements and program return on investment (ROI).
  • Strong project management experience and the ability to manage and coordinate projects with multiple internal stakeholders and vendors on time
  • Excellent verbal, written, organization and interpersonal skills required.
  • Versed in MS Office tools including Word, PowerPoint, and Outlook.

Travel Requirements:

  • Approximately 65% domestic travel throughout the US. Selected candidate must live near a major airport and be able to travel regularly throughout the assigned area and attend meetings at both Mirum office and off-site locations through the US.

#LI-REMOTE

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media